Private market continues positive upward momentum in AprilForge Private Market Index outperforms public markets as core metrics remain solid.
Private market continues positive upward momentum in April
Trading
Data
Solutions
Insights
About
Procyrion is aiding the Aortix™ device, designed for percutaneous mechanical circulatory support to benefit heart and kidney functions. By pumping blood from the aortic arch to the lower aorta, it aims to reduce heart workload and improve cardiac efficiency while also enhancing renal perfusion. This could potentially aid in conditions like diuretic-resistant heart failure. Preclinical studies suggest its application in acute heart failure, renal support during cardiac procedures, myocardial infarct size reduction, and chronic heart failure management.
Procyrion is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Procyrion pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Procyrion is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
